Ingenus Pharmaceuticals
Ingenus Pharmaceuticals, founded in 2010, is a privately owned U.S. based pharmaceutical company that develops, manufactures, and commercializes quality generic medications with a focus on cost-effective solutions. The company operates facilities in the U.S., India, and Switzerland, and is known for its high quality standards and commitment to diversity, equity, and inclusion.
Company Overview
Ingenus Pharmaceuticals, founded in 2010, is a privately owned pharmaceutical company based in the U.S. The company focuses on the development, manufacturing, and commercialization of high-quality generic medications. With a commitment to cost-effective solutions, Ingenus aims to benefit patients, suppliers, and stakeholders. The company is known for its high quality standards and strives to improve patient access to medications while maintaining a philosophy of quality over quantity.
Global Locations
Ingenus Pharmaceuticals has a robust global presence with locations in Orlando, Florida; Denville, New Jersey; Fairfield, New Jersey; Hyderabad, India; and Lugano, Switzerland. The corporate headquarters are located in Orlando, Florida. Research and development facilities are based in Denville, New Jersey, and Hyderabad, India, operating under the name RiconPharma. Manufacturing facilities specialize in different dosage forms and are situated in Fairfield, New Jersey, and Lugano, Switzerland.
Manufacturing Facilities
Ingenus Pharmaceuticals operates manufacturing facilities in Fairfield, New Jersey, and Lugano, Switzerland. The New Jersey plant, registered with the USFDA, specializes in finished solid oral dosage forms and has undergone FDA inspections. The Switzerland facility, accredited by SwissMedic, focuses on oncology finished dosage forms, including cytotoxic sterile injectable products in both liquid and lyophilized forms. These plants support Ingenus's high standards in producing diverse and specialized generic medications.
Research and Development
Ingenus Pharmaceuticals conducts its research and development activities at facilities in Denville, New Jersey, and Hyderabad, India, through its RiconPharma division. These R&D centers focus on innovative solutions to produce cost-effective and high-quality generic medications. The New Jersey facility is USFDA registered, ensuring compliance with stringent regulatory standards to support the company’s mission of improving patient access to essential medications.
Product Range
Ingenus Pharmaceuticals offers a broad portfolio of generic medications, including oral solids and specialized oncology products. Notable products include Arsenic Trioxide Injection, Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride Capsules. The company employs a strong network of strategic partners to enhance its marketing and manufacturing capabilities, ensuring the distribution of quality medications to a wide range of patients.